BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Prognosis
7 results:

  • 1. The immune regulation of bcl3 in glioblastoma with mutated IDH1.
    Fan S; Wu N; Chang S; Chen L; Sun X
    Aging (Albany NY); 2022 Apr; 14(9):3856-3873. PubMed ID: 35488886
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Trends in inpatient palliative care use for primary brain malignancies.
    Kubendran S; Schockett E; Jackson E; Huynh-Le MP; Roberti F; Rao YJ; Ojong-Ntui M; Goyal S
    Support Care Cancer; 2021 Nov; 29(11):6625-6632. PubMed ID: 33945016
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prediction of Response to Stereotactic Radiosurgery for brain Metastases Using Convolutional Neural Networks.
    Cha YJ; Jang WI; Kim MS; Yoo HJ; Paik EK; Jeong HK; Youn SM
    Anticancer Res; 2018 Sep; 38(9):5437-5445. PubMed ID: 30194200
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive molecular biomarker identification in breast cancer brain metastases.
    Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
    J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?
    Zanello M; Roux A; Ursu R; Peeters S; Bauchet L; Noel G; Guyotat J; Le Reste PJ; Faillot T; Litre F; Desse N; Emery E; Petit A; Peltier J; Voirin J; Caire F; Barat JL; Vignes JR; Menei P; Langlois O; Dezamis E; Carpentier A; Dam Hieu P; Metellus P; Pallud J;
    J Neurooncol; 2017 Nov; 135(2):285-297. PubMed ID: 28726173
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High CD133 Expression Is Associated with Worse prognosis in Patients with Glioblastoma.
    Zhang W; Chen H; Lv S; Yang H
    Mol Neurobiol; 2016 May; 53(4):2354-60. PubMed ID: 25983032
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson cancer Center experience from 1978 to 1998.
    Kunschner LJ; Kuttesch J; Hess K; Yung WK
    Neuro Oncol; 2001 Jul; 3(3):167-73. PubMed ID: 11465397
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.